Drug effective in preventing stroke, reducing bleeding, cardiovascular death in patients with atrial fibrillation
Wednesday, November 20, 2013 - 22:30
in Health & Medicine
A late-breaking clinical trial demonstrates that high- and low-dose edoxaban were at least as effective in preventing stroke or systemic embolism (blood clot), while significantly reducing bleeding and cardiovascular death, compared to warfarin.